Notice of Intent to issue a Sole Source Award for Research and Development of 10,000 lateral flow devices for pre-clinical and clinical studies to rapidly detect HIV
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Centers for Disease Control and Prevention (CDC) Division of HIV Prevention has issued a Notice of Intent to issue a Sole Source Award for the Research and Development of 10,000 lateral flow devices to rapidly detect HIV antiretroviral usage. The CDC intends to award a firm fixed-price purchase order to Beacon Scientific INC. Responses from other interested parties are due by June 3, 2026.
Scope of Work
This opportunity involves the manufacture of 10,000 lateral flow devices. These devices are intended for use in pre-clinical and clinical studies to evaluate their performance and utility in rapidly detecting HIV antiretroviral usage in point-of-care facilities.
Contract & Timeline
- Type: Notice of Intent to Sole Source Award (Firm Fixed Price Purchase Order)
- Intended Awardee: Beacon Scientific INC
- Purpose: Manufacture of 10,000 lateral flow devices for HIV detection studies
- NAICS: 541714 – Research and Development in Biotechnology (except Nanobiotechnology)
- Set-Aside: Total Small Business Set-Aside (FAR 19.5) - Note: This is a Notice of Intent for a Sole Source award.
- Response Due: June 3, 2026 (Email responses to zvm0@cdc.gov by June 2, 2026)
- Published: May 12, 2026
Evaluation
This notice is not a request for competitive quotations. However, all quotations/responses received within the specified timeframe will be considered by the government solely for the purpose of determining whether to conduct a competitive procurement. A determination not to complete the proposed contract based on responses is at the government's discretion.
Additional Notes
Beacon Scientific INC is identified as the only source capable of performing the required work due to their proprietary state-of-the-art nanoparticle materials, which produce superior results compared to other LFA design companies.